Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
301
datasets available to search
ShareScore release 0.9.0
Dataset results
301 results for “sitagliptin”
Sitagliptin Cardiovascular Outcomes Study (MK-0431-082)
ClinicalTrials.gov study NCT00790205. IPD Sharing: YES. Countries: 0. Publications: 19.
Effects of Sitagliptin on Gastric Emptying in Healthy Subjects
ClinicalTrials.gov study NCT00501657. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)
ClinicalTrials.gov study NCT01357135. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)
ClinicalTrials.gov study NCT01159847. IPD Sharing: Not stated. Countries: 1. Publications: 27.
Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00551590. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)
ClinicalTrials.gov study NCT00509236. IPD Sharing: YES. Countries: 0. Publications: 1.
Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)
ClinicalTrials.gov study NCT00511108. IPD Sharing: YES. Countries: 0. Publications: 1.
Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
ClinicalTrials.gov study NCT01296412. IPD Sharing: YES. Countries: 0. Publications: 1.
Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)
ClinicalTrials.gov study NCT01177384. IPD Sharing: YES. Countries: 0. Publications: 1.
Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)
ClinicalTrials.gov study NCT02577003. IPD Sharing: YES. Countries: 0. Publications: 1.
Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)
ClinicalTrials.gov study NCT01340768. IPD Sharing: YES. Countries: 0. Publications: 2.
Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes
ClinicalTrials.gov study NCT02324010. IPD Sharing: Not stated. Countries: 1. Publications: 30.
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
ClinicalTrials.gov study NCT02791490. IPD Sharing: YES. Countries: 0. Publications: 1.
Perioperative Sitagliptin Medication for Reduction of the Inflammatory Response Associated With Cardiopulmonary Bypass
ClinicalTrials.gov study NCT05725798. IPD Sharing: NO. Countries: 1. Publications: 4.
Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome
ClinicalTrials.gov study NCT00721552. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals
ClinicalTrials.gov study NCT00813228. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Sitagliptin for the Treatment of Type 2 Diabetes
ClinicalTrials.gov study NCT04495881. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081)
ClinicalTrials.gov study NCT00730275. IPD Sharing: YES. Countries: 0. Publications: 1.
Sitagliptin Treatment in Diabetic COVID-19 Positive Patients
ClinicalTrials.gov study NCT04382794. IPD Sharing: NO. Countries: 1. Publications: 9.
Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)
ClinicalTrials.gov study NCT00541229. IPD Sharing: YES. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.